课题基金 / 基金详情

A Therapy for the Treatment of the Inherited Childhood Blinding Disorder Familial Exudative Vitreoretinopathy

A Therapy for the Treatment of the Inherited Childhood Blinding Disorder Familial Exudative Vitreoretinopathy
治疗遗传性儿童失明症家族性渗出性玻璃体视网膜病变的疗法
批准号:
344696
负责人:
McMaster Christopher R
金额:
$43.16万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2016
资助国家:
加拿大
项目状态:
已结题
起止时间:
2016-03-01 至 2021-03-01

项目摘要

项目成果

McMaster Christopher R的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have made a class of novel drugs to treat the inherited childhood blinding disorder familial exudative vitreoretinopathy (FEVR). FEVR is characterized by lack of vascularization of the retina followed by secondary aberrant 'neo'-vascularization that ca
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel Antibiotic Class to Treat Diabetic Ulcer Infections
  • 批准号:
    321280
  • 项目类别:
    Operating Grants
  • 资助金额:
    $43.97万
  • 财政年份:
    2015
  • 负责人:
    McMaster Christopher R
  • 依托单位:
A Novel Antibiotic Class to Treat Diabetic Ulcer Infections
  • 批准号:
    309932
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2014
  • 负责人:
    McMaster Christopher R
  • 依托单位:
Integrating Phosphatidylcholine Metabolism with Cell Growth Regulation
  • 批准号:
    221878
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2010
  • 负责人:
    McMaster Christopher R
  • 依托单位:
海外基金